KEY POINTS
- Cespira joint venture revenue jumped 33% to $22.2M — the core business is genuinely growing.
- Net loss at Cespira narrowed 65% to $2.5M, down from $7.1M a year ago — moving in the right direction.
- Cash stands at just $24.5M — thin for a company still burning cash while waiting on a second OEM decision.
Westport reported Q1 2026 results on May 15. If you've never heard of them, that's fine — most people haven't. They make high-pressure direct injection (HPDI) natural gas fuel systems for heavy-duty trucks, primarily through a joint venture called Cespira with Robert Bosch. The business is real. The question is whether it scales fast enough to justify the risk.
What they reported
Westport Fuel Systems — the company that builds natural gas and hydrogen fuel systems for heavy trucks through its Cespira joint venture with Bosch — reported Q1 2026 with Cespira revenue up 33% to $22.2 million, gross margin improving to 7% from 3%, and a net loss at the joint venture narrowing 65% to $2.5 million, while the parent company's total cash dropped to $24.5 million.
Beat or miss
Westport doesn't report against a clean Wall Street EPS consensus given its micro-cap status and thin analyst coverage, but the directional results were positive — Cespira's 33% revenue growth and 65% loss reduction beat the internal trajectory while cash burn improved by $5.2 million year over year, suggesting the operational leverage is starting to show up.
What the CEO actually said about the future
CEO Daniel Sceli spent the call talking about two things: Volvo milestones and a mysterious second OEM. Volvo surpassed 10,000 natural gas trucks on the road with Cespira's HPDI system — that's a real validation milestone, not marketing fluff. New manufacturing facilities in Cambridge, Ontario and Zhengzhou, China came online this quarter, which is operationally significant. So far so good.
But here's the thing. The second OEM — which has been in truck trials and negotiations for what seems like a very long time — is supposedly going to make a commercialization decision "by year end." Management said this in a tone that suggests they've been saying it for a while. No name. No binding terms. Just "ongoing negotiations." That's the entire growth catalyst for the bear-to-bull thesis on this stock, and it's still hanging. If the second OEM commits, the addressable market expands significantly. If they walk, or delay again, Westport is a company with $24.5 million in cash and $1.9 million in debt it's trying to retire, burning roughly $3 million per quarter in operating cash — which means the runway is tighter than the bullish narrative implies.
What it means for the stock in plain terms
This is a binary setup dressed as a growth story.
The operational improvements are real — Cespira is genuinely getting better, loss reduction is meaningful, and Volvo's 10,000-truck milestone proves the technology works at scale in commercial fleets. But institutional investors have heard the second OEM story before, and thin cash with a year-end catalyst creates a known deadline. If the decision slips to 2027, Westport will almost certainly need to raise capital — which, at current share prices, would be dilutive. The North American market interest from ACT Expo is promising but early-stage. Until that second OEM signs something binding, the stock is essentially a call option on a decision that keeps not happening yet.
The one thing beginners should take away
"Moving in the right direction" isn't the same as being a safe investment. Westport's losses are narrowing and growth is real, but with $24.5M in cash and a binary catalyst that's been "coming by year end" for multiple quarters, the risk is that you buy a real improvement story and get diluted anyway when the company needs to raise money before the big contract actually closes.